ALTANA PHARMA AG has a total of 1,802 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ENPHARMA L P, KADEREIT DIETER and NEOMED INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 243 | |
#2 | Canada | 187 | |
#3 | EPO (European Patent Office) | 187 | |
#4 | United States | 155 | |
#5 | Australia | 104 | |
#6 | Brazil | 78 | |
#7 | Mexico | 72 | |
#8 | South Africa | 72 | |
#9 | China | 71 | |
#10 | Poland | 65 | |
#11 | Argentina | 52 | |
#12 | New Zealand | 46 | |
#13 | Republic of Korea | 44 | |
#14 | Norway | 43 | |
#15 | Taiwan | 37 | |
#16 | Croatia | 34 | |
#17 | Serbia | 34 | |
#18 | EAPO (Eurasian Patent Organization) | 30 | |
#19 | Israel | 27 | |
#20 | Hong Kong | 25 | |
#21 | Hungary | 24 | |
#22 | Czechia | 23 | |
#23 | Iceland | 23 | |
#24 | Slovakia | 22 | |
#25 | Germany | 15 | |
#26 | Peru | 10 | |
#27 | Ukraine | 10 | |
#28 | Colombia | 9 | |
#29 | Bulgaria | 8 | |
#30 | Chile | 8 | |
#31 | Estonia | 8 | |
#32 | Cyprus | 7 | |
#33 | Morocco | 6 | |
#34 | Finland | 5 | |
#35 | Georgia | 4 | |
#36 | Japan | 2 | |
#37 | Malaysia | 2 | |
#38 | Netherlands | 2 | |
#39 | Cuba | 1 | |
#40 | United Kingdom | 1 | |
#41 | Luxembourg | 1 | |
#42 | Latvia | 1 | |
#43 | Montenegro | 1 | |
#44 | Saudi Arabia | 1 | |
#45 | Tunisia | 1 | |
#46 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Weapons |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies | |
#5 | Peptides | |
#6 | Steroids | |
#7 | Special acyclic compounds | |
#8 | Acyclic or carbocyclic compounds | |
#9 | Microorganisms | |
#10 | Explosiveness missiles |
# | Name | Total Patents |
---|---|---|
#1 | Postius Stefan | 328 |
#2 | Simon Wolfgang-Alexander | 325 |
#3 | Buhr Wilm | 314 |
#4 | Kromer Wolfgang | 298 |
#5 | Hatzelmann Armin | 273 |
#6 | Zimmermann Peter Jan | 229 |
#7 | Kley Hans-Peter | 211 |
#8 | Palmer Andreas | 183 |
#9 | Brehm Christof | 177 |
#10 | Marx Degenhard | 169 |
Publication | Filing date | Title |
---|---|---|
ZA200704696B | Triazolophthalazines | |
WO2007045622A1 | Oxazolo [4 , 5-b] pyridine compounds as nitric oxide synthase inhibitors | |
ZA200608482B | Novel tetrahydropyridothiophenes | |
WO2007039580A1 | Imidazolyl-substituted benzophenone compounds | |
WO2007039581A1 | Imidazolyl-substituted diazabenzophenone compounds | |
WO2007039578A1 | Imidazolyl-substituted azabenzophenone compounds | |
WO2007023135A1 | Isotopically substituted benzimidazole derivatives | |
ZA200606669B | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors | |
WO2006117316A1 | Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity | |
WO2006100255A1 | Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases | |
WO2006097458A1 | Novel combination | |
WO2006094942A1 | Roflumilast for the treatment of diabetes mellitus | |
CA2596501A1 | Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer | |
CA2595247A1 | Indolopyridines, benzofuranopyridines and benzothienopyridines | |
WO2006079645A1 | Novel indolopyridines , benzofuranopyridines and benzothienopyridines | |
WO2006089815A1 | Novel pyrrolodihydroisoquinolines as pde10 inhibitors | |
WO2006075012A2 | Pyrrolodihydroisoquinolines as antiproliferative agents | |
CA2591991A1 | Triazolophthalazines | |
ZA200507244B | Aerosol antiperspirant with polyamide Pyrrolo-dihydroisoquinoline derivatives as PDE10 inhibitors | |
MX2007004022A | Difluoro-substituted imidazopyridines. |